- Home
- AXSM vs ASH Comparison
AXSM vs ASH Comparison
Compare AXSM & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ASH
- Stock Information
- Founded
- AXSM 2012
- ASH 1924
- Country
- AXSM United States
- ASH United States
- Employees
- AXSM N/A
- ASH N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ASH Specialty Chemicals
- Sector
- AXSM Health Care
- ASH Consumer Discretionary
- Exchange
- AXSM Nasdaq
- ASH Nasdaq
- Market Cap
- AXSM 4.4B
- ASH 4.1B
- IPO Year
- AXSM 2015
- ASH N/A
- Fundamental
- Price
- AXSM $98.19
- ASH $77.65
- Analyst Decision
- AXSM Strong Buy
- ASH Buy
- Analyst Count
- AXSM 14
- ASH 7
- Target Price
- AXSM $124.93
- ASH $102.50
- AVG Volume (30 Days)
- AXSM 536.9K
- ASH 465.4K
- Earning Date
- AXSM 11-12-2024
- ASH 11-06-2024
- Dividend Yield
- AXSM N/A
- ASH 2.08%
- EPS Growth
- AXSM N/A
- ASH 1.05
- EPS
- AXSM N/A
- ASH 3.35
- Revenue
- AXSM $338,457,000.00
- ASH $2,113,000,000.00
- Revenue This Year
- AXSM $40.67
- ASH $1.09
- Revenue Next Year
- AXSM $69.27
- ASH $4.54
- P/E Ratio
- AXSM N/A
- ASH $19.29
- Revenue Growth
- AXSM 51.47
- ASH N/A
- 52 Week Low
- AXSM $60.28
- ASH $75.04
- 52 Week High
- AXSM $105.00
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- AXSM 61.45
- ASH 36.51
- Support Level
- AXSM $90.86
- ASH $75.04
- Resistance Level
- AXSM $105.00
- ASH $78.20
- Average True Range (ATR)
- AXSM 4.06
- ASH 1.82
- MACD
- AXSM 0.44
- ASH -0.42
- Stochastic Oscillator
- AXSM 64.04
- ASH 18.84
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.